Owens & Minor New Bank Loan Rated 'BB'
NEW YORK (Standard & Poor's CreditWire) May 12, 2000--Standard & Poor's today assigned its double-'B' bank loan rating to Owens & Minor Inc.'s $225 million senior unsecured revolving credit facility due 2003. In addition, Standard & Poor's withdrew its existing double-'B' bank loan rating for Owens & Minor, since it has been replaced by the new facility. At the same time, Standard & Poor's affirmed its double-'B' corporate credit, its single-'B'-plus subordinated debt rating, and its single-'B' preferred stock rating on the company. The outlook is stable. The rating on the bank facilities is the same as the corporate credit rating. Since the facility is unsecured, the bankers will fare the same as other senior creditors in the event of a default. Currently ample asset coverage may be expected to dwindle in a default scenario. The speculative-grade ratings for Owens & Minor reflect the company's sound market position in a competitive and dynamic industry, offset by expectations for moderate-size debt-financed acquisitions. The Richmond, Virginia-based company is the largest domestic pure distributor of medical supplies and devices to hospitals. Size, breadth of product offerings, computerized order-entry and tracking systems, and service quality provide competitive advantages. Moreover, inclusion in almost all the major group purchasing organizations not only provides substantial customer diversification, but also allowed Owens & Minor to replace revenues lost from the cancellation of the Columbia/HCA contract in 1998. In addition, by focusing on integrated delivery networks, the company is increasing its breadth of clients to include alternate site providers, especially surgery centers, large physician groups, and rehabilitation providers. Furthermore, enhanced working capital management has aided the company in generating free operating cash flow. Nevertheless, strong pricing pressures limit financial flexibility. Considerable consolidation in the industry, including the entry of well-entrenched pharmaceutical distributors into the medical-supply distribution business and the emergence of e-commerce firms present new risks. Although inventory turnover is improving, it remains lackluster, at less than 10 times per year. Still, Standard & Poor's expects funds flow to adjusted debt to be at least 15%. Outlook: Stable The rating reflects some capacity for the company to make moderate-size debt-financed acquisitions, Standard & Poor's said. -- CreditWire
Credit Analyst: | Jean C Stout, New York (1) 212-438-7865 |
No content (including ratings, credit-related analyses and data, valuations, model, software, or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced, or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of Standard & Poor’s Financial Services LLC or its affiliates (collectively, S&P). The Content shall not be used for any unlawful or unauthorized purposes. S&P and any third-party providers, as well as their directors, officers, shareholders, employees, or agents (collectively S&P Parties) do not guarantee the accuracy, completeness, timeliness, or availability of the Content. S&P Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an “as is” basis. S&P PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED, OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.
Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P’s opinions, analyses, and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment, and experience of the user, its management, employees, advisors, and/or clients when making investment and other business decisions. S&P does not act as a fiduciary or an investment advisor except where registered as such. While S&P has obtained information from sources it believes to be reliable, S&P does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives. Rating-related publications may be published for a variety of reasons that are not necessarily dependent on action by rating committees, including, but not limited to, the publication of a periodic update on a credit rating and related analyses.
To the extent that regulatory authorities allow a rating agency to acknowledge in one jurisdiction a rating issued in another jurisdiction for certain regulatory purposes, S&P reserves the right to assign, withdraw, or suspend such acknowledgement at any time and in its sole discretion. S&P Parties disclaim any duty whatsoever arising out of the assignment, withdrawal, or suspension of an acknowledgment as well as any liability for any damage alleged to have been suffered on account thereof.
S&P keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain business units of S&P may have information that is not available to other S&P business units. S&P has established policies and procedures to maintain the confidentiality of certain nonpublic information received in connection with each analytical process.
S&P may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P reserves the right to disseminate its opinions and analyses. S&P's public ratings and analyses are made available on its Web sites, www.spglobal.com/ratings (free of charge), and www.ratingsdirect.com (subscription), and may be distributed through other means, including via S&P publications and third-party redistributors. Additional information about our ratings fees is available at www.spglobal.com/usratingsfees.
Any Passwords/user IDs issued by S&P to users are single user-dedicated and may ONLY be used by the individual to whom they have been assigned. No sharing of passwords/user IDs and no simultaneous access via the same password/user ID is permitted. To reprint, translate, or use the data or information other than as provided herein, contact S&P Global Ratings, Client Services, 55 Water Street, New York, NY 10041; (1) 212-438-7280 or by e-mail to: research_request@spglobal.com.